These results are in line with our observation that RB94 was cytotoxic to multiple NSCLC types irrespective of their genetic makeup (i.e., RB status), suggesting that SGT-94 could be expanded to other tumor types irrespective of their native RB status [19]. Here, RB1 is linked to neoplasm.